CLINICAL CHEMISTRY AND LABORATORY MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2024-02-07 1241ccbbm97(暂无昵称) 来自江苏省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2022-03-05 sunrise19890224

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：miRNA;biomarker
经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi

64 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2023-05-20 苏还真来自福建省

2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向

70 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2022-11-21 芳芳7867

这个杂志的Template for Ethical and Legal Declarations有模板么？

56 0

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2022-08-15 12216d9bm93(暂无昵称)

tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。

59 0

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2018-10-31 wait2020

审稿速度:1.0 | 投稿命中率:25.0
经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。

306 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2021-12-29 MS68862005

老牌期刊和新出版期刊是否都要选一些？

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2021-12-29 MS68862005

除文章内容和质量外，选刊时还需注意什么？

75 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2021-06-01 18842244c3m

暂无

89 0

[GetPortalCommentsPageByObjectIdResponse(id=2186305, encodeId=986b2186305e3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：with editor 9天状态变成 All Reviews Complete，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93bd2462096, createdName=1241ccbbm97(暂无昵称), createdTime=Wed Feb 07 08:49:22 CST 2024, time=2024-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1199761, encodeId=c2111199e611e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：miRNA;biomarker 经验分享：在这本期刊中过3篇，对于此杂志投稿各个阶段状态非常的了解。有需要了解这本杂志任何情况的都可以问我。v：Langzhongxiangxiuxi, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sat Mar 05 22:11:09 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137989, encodeId=dcdd213e989e9, content=2023年发表了一篇，初审2周，二审和三审都是1周，人工智能生物标志物方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eovD1icUcEVCJ8GYoZOtCjzr7JU0lgQicRN69PANyYicu30ia4mGn8fCZQFgZPA0HDOnJfSDCG8WTyalg/132, createdBy=3d842535360, createdName=苏还真, createdTime=Sat May 20 09:59:18 CST 2023, time=2023-05-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2101745, encodeId=4a982101e4515, content=这个杂志的Template for Ethical and Legal Declarations有模板么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/19/07a9fbf26fffca83d5a656095b2ab7c2.jpg, createdBy=56c91652218, createdName=芳芳7867, createdTime=Mon Nov 21 12:34:10 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238821, encodeId=510d123882154, content=tif.格式图片可以上传，但转换不成功，尝试了各种修改，还是不行，求各位大神指教。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/03/02/07f11eac54199429f8938fb477501632.jpg, createdBy=d4822305586, createdName=12216d9bm93(暂无昵称), createdTime=Mon Aug 15 15:50:58 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562574, encodeId=d0425625e452, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：抱着试试的心态投稿检验界第二牛的杂志，审稿意见是修改后重投，重投指环王，二十天一直是with editor ，于是给编辑发邮件询问情况，编辑很快回复，当天晚上便给审稿意见 decision accept with minor revision.看到意见后有点不敢相信呢，于是按照意见修改后，当天即accept，努力还是会有结果的，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Wed Oct 31 00:00:00 CST 2018, time=2018-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088806, encodeId=17331088806cc, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088805, encodeId=ec7b10888050d, content=除文章内容和质量外，选刊时还需注意什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970030, encodeId=8f0f9e003036, content=暂无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9def4691011, createdName=18842244c3m, createdTime=Tue Jun 01 10:09:31 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566092, encodeId=6d3c5660927d, content=没有版面费LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, beContent=LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/04/11027488c75c2559dca38fd79e08bf1a.jpg, createdBy=c17f2335117, createdName=wait2020, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=)]

2019-01-25 wait2020

没有版面费LancetYAO 2018-12-25 00:00:00 发表:
版面费多少？

LancetYAO 2018-12-25 00:00:00 发表: 版面费多少？

261 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务